UK Life Sciences Company Directory

Enzymatic synthetic DNA manufacture for gene therapy and molecular biology

NunaBio is a specialist DNA synthesis company developing a cell-free enzymatic platform for scalable production of synthetic DNA, including long oligonucleotides, whole genes and…

Novel methylation amplification platform for clinical genomic diagnostics

Syndex Bio is a Cambridge-based biotechnology company developing a proprietary platform technology that enables amplification of DNA methylation for the first time. Unlike…

Non-profit CRO specialising in clinical trial data and biostatistics

Frontier Science (Scotland) is a not-for-profit contract research organisation providing data management, biostatistics, and quality assurance services for clinical trials. The…

AAV gene therapy targeting the seizure focus in refractory epilepsy

EpilepsyGTx is a biotechnology company developing gene therapies for focal refractory epilepsy, a condition in which seizures arise from a specific brain region and do not respond…

Peptide discovery platform targeting cell-surface therapeutic targets

Orbit Discovery is a drug discovery company providing peptide lead identification services using a proprietary bead-based peptide display engine combined with microfluidic…

Immuno-oncology therapies targeting the nfP2X7 cancer receptor

Biosceptre is a UK-headquartered clinical-stage biotechnology company developing cancer therapeutics based on its proprietary nfP2X7 platform. The nfP2X7 receptor is a…

Defined live bacterial consortia for oncology and inflammatory bowel disease

Microbiotica is a clinical-stage biopharmaceutical company developing oral live biotherapeutic products comprising defined consortia of gut commensal bacterial strains. Candidate…

Cell and gene therapy CDMO with clinical and commercial manufacturing

RoslinCT is a CDMO specialising in advanced cell and gene therapies. Operating purpose-built cGMP facilities at Edinburgh BioQuarter and in Hopkinton, Massachusetts, it provides…

ADC oncology company developing novel spliceosome-modulating payloads

Akari Therapeutics is a clinical-stage biopharma company developing next-generation bi-functional antibody-drug conjugates for cancer treatment. Its proprietary ADC platform…

Clinical-stage biopharma developing treatments for cancer and rare diseases

Biodexa Pharmaceuticals is a Cardiff-based clinical-stage biopharmaceutical company advancing a pipeline of proprietary drug formulations for diseases with high unmet need. Its…

Clinical-stage biopharma targeting cancer immunotherapy and obesity

Poolbeg Pharma is a clinical-stage biopharmaceutical company developing small molecule therapies for high unmet medical needs. Its lead programme, POLB 001, is a p38 MAP kinase…

Genomics and biodata research campus near Cambridge

Wellcome Genome Campus is a 125-acre research campus in Hinxton, Cambridgeshire, owned by Wellcome. It is home to the Wellcome Sanger Institute, EMBL-EBI, Wellcome Connecting…